Bicara Therapeutics (BCAX) Times Interest Earned (2023 - 2026)
Bicara Therapeutics (BCAX) posted quarterly Times Interest Earned of -$0.55 for Q1 2026, up 99.87% year-over-year from -$0.28 in Q1 2025, and up 99.87% quarter-over-quarter from -$411.22 in Q4 2025.
Bicara Therapeutics (BCAX) Times Interest Earned (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$0.55 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 99.87% year-over-year to -$0.55; the TTM figure through Mar 2026 stood at -$1.6 (up 99.56% YoY), while the FY2025 annual figure was -$1.59, down 13.99% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.55, up from -$411.22 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.36 in Q4 2023, with the low at -$417.88 in Q1 2025.
- The 4-year median for Times Interest Earned is -$236.32 (2024), against an average of -$213.87.
- The sharpest annual moves came in 2024 and 2026: Times Interest Earned sank 73279.71% in 2024, then soared 99.87% in 2026.
- Bicara Therapeutics' Times Interest Earned stood at -$0.36 in 2023, then tumbled by 73279.71% to -$266.37 in 2024, then sank by 54.38% to -$411.22 in 2025, then jumped by 99.87% to -$0.55 in 2026.
- Business Quant data shows BCAX's Times Interest Earned at -$0.55 in Q1 2026, -$411.22 in Q4 2025, and -$406.76 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.55 |
| Dec 31, 2025 | -411.22 |
| Sep 30, 2025 | -406.76 |
| Jun 30, 2025 | -1.56 |
| Mar 31, 2025 | -417.88 |
| Dec 31, 2024 | -266.37 |
| Sep 30, 2024 | -206.28 |
| Dec 31, 2023 | -0.36 |